Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis

被引：0

作者：

Harrison, Stephen A. ^{[1
]}

Abdelmalek, Manal F. ^{[2
]}

Diehl, Anna Mae ^{[2
]}

Caldwell, Stephen ^{[3
]}

Shiffman, Mitchell L. ^{[4
]}

Ghalib, Reem ^{[5
]}

Lawitz, Eric ^{[6
]}

Rockey, Don C. ^{[7
]}

Schall, Raul E. Aguilar ^{[8
]}

Jia, Catherine ^{[8
]}

McColgan, Bryan J. ^{[8
]}

Myers, Robert P. ^{[8
]}

Subramanian, Mani ^{[8
]}

McHutchison, John G. ^{[8
]}

Muir, Andrew J. ^{[2
]}

Ratziu, Vlad ^{[15
]}

Afdhal, Nezam H. ^{[9
,10
]}

Goodman, Zachary D. ^{[11
]}

Bosch, Jaime ^{[12
,13
]}

Sanyal, Arun J. ^{[14
]}

机构：

[1] Pinnacle Clin Res, San Antonio, TX USA

[2] Duke Clin Res Inst, Durham, NC USA

[3] Univ Virginia, Charlottesville, VA USA

[4] Liver Inst Virginia, Richmond, VA USA

[5] Texas Clin Res Inst, Arlington, TX USA

[6] Univ Texas Hlth, Texas Liver Inst, San Antonio, TX USA

[7] Med Univ South Carolina, Charleston, SC USA

[8] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[9] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[10] Harvard Med Sch, Boston, MA USA

[11] Inova Fairfax Hosp, Falls Church, VA USA

[12] Univ Barcelona, Barcelona, Spain

[13] Bern Univ, Bern, Switzerland

[14] Virginia Commonwealth Univ, Richmond, VA USA

[15] Hop La Pitie Salpetriere, Paris, France

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2122

引用

页码：1120A / 1121A

页数：2

共 50 条

[1] Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis
Loomba, Rohit
Jain, Anjali
Diehl, Anna Mae
Guy, Cynthia D.
Portenier, Dana
Sudan, Ranjan
Singh, Seema
Faulkner, Claire
Richards, Lisa
Hester, Kelly D.
Okada, Lauren
Li, Xiao-jun
Mimms, Larry
Abdelmalek, Manal F.
[J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) : 1867 - +
[2] FIBROSpect® NASH serum test identifies advanced liver fibrosis in patients with nonalcoholic steatohepatitis: Results of a validation study
Abdelmalek, M.
Guy, C.
Diehl, A. M.
Li, X.
Mimms, L.
Hester, K.
Jain, A.
Loomba, R.
[J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S571 - S572
[3] PROSPECTIVE VALIDATION OF THE ENHANCED LIVER FIBROSIS (ELF) TEST FOR THE PREDICTION OF DISEASE PROGRESSION IN A RANDOMIZED TRIAL OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)
Bowlus, Christopher L.
Patel, Keyur
Hirschfield, Gideon
Guha, Neil
Chapman, Roger W.
Chazouilleres, Olivier
Ding, Dora
Jia, Catherine
McColgan, Bryan J.
Natha, Macky
Myers, Robert P.
Subramanian, Mani
McHutchison, John
Muir, Andrew J.
Goodman, Zachary
Rosenberg, William
Levy, Cynthia
[J]. GASTROENTEROLOGY, 2017, 152 (05) : S1060 - S1060
[4] The Enhanced Liver Fibrosis (ELF) Score Predicts Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH)
Younossi, Zobair
Anstee, Quentin
Trauner, Michael
Wong, Vincent W. S.
Camargo, Marianne
Henry, Linda
Stepanova, Maria
Romero-Gomez, Manuel
Lawitz, Eric
Myers, Rob
[J]. DIABETES, 2020, 69
[5] CHANGES IN FIBROSIS, BUT NOT THE NAFLD ACTIVITY SCORE (NAS), ARE ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS
Sanyal, Arun
Harrison, Stephen A.
Ratziu, Vlad
Abdelmalek, Manal F.
Diehl, Anna Mae
Caldwell, Stephen H.
Shiffman, Mitchell L.
Aguilar, Raul
Jia, Catherine
McColgan, Bryan J.
Natha, Macky
Myers, Robert P.
Subramanian, Mani
McHutchison, John
Muir, Andrew J.
Afdhal, Nezam H.
Bosch, Jaime
Goodman, Zachary
[J]. GASTROENTEROLOGY, 2017, 152 (05) : S1055 - S1055
[6] Changes in fibrosis, but not the NAFLD Activity Score (NAS), are associated with disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis
Sanyal, A.
Harrison, S.
Ratziu, V.
Abdelmalek, M.
Diehl, A.
Caldwell, S.
Shiffman, M.
Aguilar, R.
Jia, C.
McColgan, B.
Myers, R.
Subramanian, M.
McHutchison, J.
Muir, A.
Afdhal, N.
Bosch, J.
Goodman, Z.
[J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S2 - S3
[7] VALIDATION OF HISTOLOGIC AND NONINVASIVE MEASURES OF FIBROSIS AS SURROGATE ENDPOINTS OF DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
Anstee, Quentin M.
Trauner, Michael H.
Lawitz, Eric J.
Bzowej, Natalia
Vuppalanchi, Raj
Younes, Ziad
Ding, Dora
Li, Georgia
Kersey, Kathryn
Camargo, Marianne
Djedjos, Stephen
Subramanian, Mani
Myers, Robert P.
Wong, Vincent Wai-Sun
Harrison, Stephen A.
Okanoue, Takeshi
Romero-Gomez, Manuel
Goodman, Zackary
[J]. HEPATOLOGY, 2019, 70 : 1342A - 1343A
[8] Predictors of Fibrosis Progression and Regression by Histology and Morphometrically Quantified Collagen in Patients with Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Younossi, Zobair M.
Stepanova, Maria
Sanyal, Arun J.
Harrison, Stephen A.
Ratziu, Vlad
McColgan, Bryan J.
Myers, Robert P.
Subramanian, Mani
McHutchison, John G.
Afdhal, Nezam H.
Abdelmalek, Manal F.
Bosch, Jaime
Goodman, Zachary D.
[J]. HEPATOLOGY, 2017, 66 : 1171A - 1171A
[9] Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD)
Younossi, Zobair
Felix, Sean
Jeffers, Thomas
Younossi, Elena
Nader, Fatema
Pham, Huong
Afendy, Arian
Cable, Rebecca
Racila, Andrei
Younoszai, Zahra
Lam, Brian P.
Golabi, Pegah
Henry, Linda
Clement, Stephen
Stepanova, Maria
[J]. DIABETES, 2020, 69
[10] Enhanced liver fibrosis (ELF) score accurately detects advanced fibrosis in nonalcoholic fatty liver disease (NAFLD)
Stauber, R. E.
Staufer, K.
Stift, J.
Marculescu, R.
Obermayer-Pietsch, B.
Trauner, M.
Lackner, K.
[J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S563 - S563

← 1 2 3 4 5 →